Rezivertinib, CAS [[1835667-12-3]]

Produktübersicht

• Artikelname: Rezivertinib, CAS [[1835667-12-3]]
• Artikelnummer: MCE-HY-109189
• Hersteller Artikelnummer: HY-109189
• Alternativnummer: MCE-HY-109189-5MG,MCE-HY-109189-1G,MCE-HY-109189-5G,MCE-HY-109189-10MMX1ML,MCE-HY-109189-10MG,MCE-HY-109189-500MG,MCE-HY-109189-50MG,MCE-HY-109189-25MG,MCE-HY-109189-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: BPI-7711

Produktbeschreibung

Rezivertinib (BPI-7711) is an orally active, highly selective and irreversible third-generation EGFR tyrosine kinase inhibitor (TKI). Rezivertinib exhibits high potency against the common activation EGFR and the resistance T790M mutations. Rezivertinib has excellent central nervous system (CNS) penetration and has antitumor activity[1][2].

Produkteigenschaften

• Molekulargewicht: 486.57
• Reinheit: 99.62
• CAS Nummer: [1835667-12-3]
• Formel: C27H30N6O3
• Target-Kategorie: EGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound